FDA calls for stricter warnings on antibiotic after liver failure reports

An antibiotic linked to a growing number of reports of liver failure, including four deaths, should carry stricter warnings about its effect, according to an internal US Food and Drug Administration memo.

The drug’s manufacturer, Sanofi-Aventis, said it was in talks with the FDA officials about the reports.